349 related articles for article (PubMed ID: 9689113)
1. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis.
Denis C; Methia N; Frenette PS; Rayburn H; Ullman-Culleré M; Hynes RO; Wagner DD
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9524-9. PubMed ID: 9689113
[TBL] [Abstract][Full Text] [Related]
2. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
[TBL] [Abstract][Full Text] [Related]
3. Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding.
Slobodianuk TL; Kochelek C; Foeckler J; Kalloway S; Weiler H; Flood VH
J Thromb Haemost; 2019 Jan; 17(1):63-71. PubMed ID: 30565388
[TBL] [Abstract][Full Text] [Related]
4. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
5. New concepts in von Willebrand disease.
Sadler JE
Annu Rev Med; 2005; 56():173-91. PubMed ID: 15660508
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice.
Jacobi PM; Kanaji S; Jakab D; Gehrand AL; Johnsen JM; Haberichter SL
J Thromb Haemost; 2018 Mar; 16(3):546-554. PubMed ID: 29285851
[TBL] [Abstract][Full Text] [Related]
7. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models.
Denis CV; Kwack K; Saffaripour S; Maganti S; André P; Schaub RG; Wagner DD
Blood; 2001 Jan; 97(2):465-72. PubMed ID: 11154224
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor and thrombosis.
Franchini M; Lippi G
Ann Hematol; 2006 Jul; 85(7):415-23. PubMed ID: 16568319
[TBL] [Abstract][Full Text] [Related]
10. A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation.
Adam F; Casari C; Prévost N; Kauskot A; Loubière C; Legendre P; Repérant C; Baruch D; Rosa JP; Bryckaert M; de Groot PG; Christophe OD; Lenting PJ; Denis CV
Sci Rep; 2016 May; 6():26306. PubMed ID: 27212476
[TBL] [Abstract][Full Text] [Related]
11. Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.
Daidone V; Barbon G; Pontara E; Cattini GM; Gallinaro L; Zampese E; Pizzo P; Casonato A
Thromb Haemost; 2014 Dec; 112(6):1159-66. PubMed ID: 25230768
[TBL] [Abstract][Full Text] [Related]
12. Correction of a murine model of von Willebrand disease by gene transfer.
Pergolizzi RG; Jin G; Chan D; Pierre L; Bussel J; Ferris B; Leopold PL; Crystal RG
Blood; 2006 Aug; 108(3):862-9. PubMed ID: 16638935
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
14. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.
Nichols TC; Samama CM; Bellinger DA; Roussi J; Reddick RL; Bonneau M; Read MS; Bailliart O; Koch GG; Vaiman M
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2455-9. PubMed ID: 7708664
[TBL] [Abstract][Full Text] [Related]
15. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis.
Swystun LL; Michels A; Lillicrap D
J Thromb Haemost; 2023 Aug; 21(8):2007-2019. PubMed ID: 37085036
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models.
Brill A; Fuchs TA; Chauhan AK; Yang JJ; De Meyer SF; Köllnberger M; Wakefield TW; Lämmle B; Massberg S; Wagner DD
Blood; 2011 Jan; 117(4):1400-7. PubMed ID: 20959603
[TBL] [Abstract][Full Text] [Related]
17. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
18. Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants.
Marx I; Lenting PJ; Adler T; Pendu R; Christophe OD; Denis CV
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):419-24. PubMed ID: 18187670
[TBL] [Abstract][Full Text] [Related]
19. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect.
Castillo R; Escolar G; Monteagudo J; Aznar-Salatti J; Reverter JC; Ordinas A
Transfusion; 1997 Aug; 37(8):785-90. PubMed ID: 9280321
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD.
Shi Q; Fahs SA; Mattson JG; Yu H; Perry CL; Morateck PA; Schroeder JA; Rapten J; Weiler H; Montgomery RR
Blood Adv; 2022 May; 6(9):2778-2790. PubMed ID: 35015821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
